Top Story

Morning Read: Martin Shkreli takes over KaloBios, is a more powerful brand than the Kardashians

Plus, NIH ends support for invasive research on chimpanzees and Sanofi and AstraZeneca said they had agreed a direct exchange of 210,000 chemical compounds.

TOP STORIES

The man is not going to go away. Martin Shkreli bought half the shares of KaloBios and is now running that company, too. And, people hate this guy so much that the stock went up 400 percent. I guess investors see him as some cross between a Big Pharma Pol Pot and King Midas. – Chicago Tribune & Forbes

LIFE SCIENCES

Sponsored Post

Physician Targeting Using Real-time Data: How PurpleLab’s Alerts Can Help

By leveraging real-time data that offers unprecedented insights into physician behavior and patient outcomes, companies can gain a competitive advantage with prescribers. PurpleLab®, a healthcare analytics platform with one of the largest medical and pharmaceutical claims databases in the United States, recently announced the launch of Alerts which translates complex information into actionable insights, empowering companies to identify the right physicians to target, determine the most effective marketing strategies and ultimately improve patient care.

Axsome Therapeutics has raised $51 million in an IPO to support its work on a non-opioid treatment for chronic pain. — FierceBiotech

Boston Scientific said today it won CE Mark approval in the European Union for its Watchman FLX left atrial appendage closure device. It also announced the device has been successfully implanted in its first set of patients. — MassDevice

Medisafe released a study that 40 percent of previously non-adherent users became adherent after using “Medfriend,” which is a social support feature that alerts caregivers when a patient isn’t filling their prescriptions. — PRNewswire

Sanofi and AstraZeneca said they had agreed a direct exchange of 210,000 chemical compounds from their respective libraries in a new twist on the drive to boost open innovation. — Reuters

PAYERS/PROVIDERS

Seventeen New Jersey hospitals will file an appeal challenging Gov. Chris Christie’s (R) administration’s approval of a new set of discounted health plans by the state’s largest health insurer, Horizon Blue Cross Blue Shield of New Jersey. — Becker’s Hospital Review

TECH

Switzerland-based dacadoo has raised an undisclosed sum from European investors for its employee wellness platform. — MobiHealthNews

POLITICS

The National Institutes of Health announced that it would end its support for invasive research on chimpanzees and retire the 50 chimps that it had set aside for future biomedical research. — The New York Times

The Centers for Medicare & Medicaid Services released a new report showing that consumers have received more than $2.4 billion premium rebates since 2011 because the Affordable Care Act requires that health insurance companies spend at least 80 percent of premium dollars on health care. — CMS

A LITTLE BIT EXTRA

Beneath the ground that used to house the MIT’s Compton Laboratories, builders just discovered a time capsule labeled “Do not open until 2957 AD.” That’s pretty intriguing. — IFLScience

Topics